Figure 3From: Oncogenic reg IV is a novel prognostic marker for glioma patient survival Kaplan-Meier survival curves for glioma patients in WHO grade I (A), grade II (B), grade III (C), grade IV (D), and all patients (E) with high and low expression of Reg IV. Back to article page